Bill Faloon, the cofounder of Life Extension Foundation, takes 5-6mg/weekly dose of Rapamycin. Here is the latest version of the list with now 17 longevity leaders who also take Rapamycin. With the female edition it’s 22. If I have missed someone just let me know.
10 Likes
Adding their approximate age too might be helpful
5 Likes
AJD
#3
It would be helpful to know their ages. Providing dosages without any context isn’t very helpful unless the goal is simply to “promote” Rapamycin.
2 Likes
blsm
#4
I’d be interested in their height and weight as well but that’s probably getting too personal.
@blsm, @AJD, @qBx123Yk I tried to get info on weight, height and age but it feels like it gets too personal because I have not got answer on those questions when I have asked. But I have one other project ongoing that will probably provide this info in future in a nice natural way 
2 Likes
AJD
#6
I’m not to worried about height and weight. There seems to be some consensus on 0.1 mg/kg. And that correlates with my casual knowledge of most of their body types. But age would be useful-- and it’s not so personal. Many on this group are quite young. But for those of us middle-aged and above, the scale from dosage at 40, 50, 60, etc is quite relevant.
In particular, I would really like to know Matt Kaeberlein’s rationale for cycling as opposed to continuous dosing. I knew that he had done that a couple of years ago when he first took it for his shoulder. I find it interesting that he is still doing it. Since he’s the outlier in the group, and probably the most rigorous of the researchers, that would interest me…(especially as I have just completed my 10th week)…
I guess you meant 0.1mg/kg and not 1mg/kg?
I will see if I can get the age in there by using google on them and on those I don’t know I will skip the age for now.
Next time I interview Matt I will ask him about his rationality about cycling and not 
3 Likes
Hello Krister
Your list shows each person’s dose/week. Do you know whether these are once-per-week doses, or are they taking small doses daily to total these weekly numbers?
Thank you!
I’m surprised that Blagosklonny is only on 8mg weekly.
1 Like
For longevity purposes rapamycin is typically only dosed once per week or sometimes once every two weeks (Bryan Johnson)
2 Likes
In the dose regime when it says weekly it’s once per week. That is the most common dose regime used.
1 Like
AJD
#12
Indeed I did mean that. Thanks! (I wouldn’t want to be responsible for someone dosing themselves off my typo)!
Yes, very interested in the cycling rationale.
AJD
#13
The weekly dosing is so that the drug reaches its peak quickly, and then clears from the body completely before the next dosage. If you take it daily at a fractional dosage you likely keep a continuous blood level but don’t ever have as high a peak concentration or ever clear it out completely.
Thank you for all the hard work going into gathering the data! Was the Peter Attia’s dosage you listed based on a particular podcast or article? The last one I had noted was 6mg but now I’m thinking I may have missed a more recent update.
2 Likes
Thanks, in a quite recent Andrew Huberman podcast Peter said for example this.
“I take 8 milligrams once a week for as long as I can tolerate it but I usually have to take breaks. I get these vicious ulcers. Little mouth sores. About 10% of people get them… I’m probably on it for two months and of it for a month.”
Source: https://www.youtube.com/watch?v=79p1X_7rAMo&t=1089s
2 Likes
mondagai
#16
This is anecdotal, but the higher number of male researchers taking rapamycin v females (to me) underscores the unknowns with rapamycin. I reckon changes in the numbers of female scientists taking rapamycin would be a good proxy for changes in scientific consensus among rapamycin researchers (in either direction), on its benefits and risks for longevity.
One reason why I think we don’t see more females in the list is that males tend to be more outspoken about this. It is also a bit of a risk to publicly announce that you self-experiment with Rapamycin. There are so many emotions that it can create and also potential conflicts with others. So I can fully understand that many don’t want to publicly announce that they take Rapamycin. I think things will change when we get more data around it. When the results from the VIBRANT rapamycin trial comes, that may also result in that more females will open up.
One other reason is also that there are much more males in the longevity field than females. It’s more males here in this discussion forum. At longevity conferences it is more men than females and also often if you look at the speakers list. But I think this will change in the future.
3 Likes
Jonas
#18
If we look at the field, there are a lot of well-known male longevity researchers than female.
Also there are quite a few well-known tech VC are taking them.
1 Like
I also suspect that since testosterone tends to make males more likely to take risks in general, that men will be more likely to take the calculated risk of trying rapamycin.
4 Likes
This reminds of the different humoristic images of why females live longer than males. Here is one.
3 Likes
